It was reported that decreased immunohistochemical expression of LEPR was associated with ER status and triple negativity and suggested that lower expression of the LEPR (rather than higher expression as hypothesized) is an important biomarker of breast cancer associated with aggressiveness, separated from race, BMI, and menopausal status [80]. This evidence concerns the gene ESR1 and breast carcinoma.